Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 43, 188-191, January 1, 1983]
© 1983 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Solt, D. B.
Right arrow Articles by Farber, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Solt, D. B.
Right arrow Articles by Farber, E.

Promotion of Liver Cancer Development by Brief Exposure to Dietary 2-Acetylaminofluorene plus Partial Hepatectomy or Carbon Tetrachloride1

Dennis B. Solt2, Edmundo Cayama3, Hiroyuki Tsuda4, Katsuhiko Enomoto5, George Lee and Emmanuel Farber6

Department of Pathology, University of Toronto, Toronto, Ontario M5G 1L5, Canada

Adult male Fischer rats were exposed to a necrogenic dose (200 mg/kg) of diethylnitrosamine or to nonnecrogenic doses of N-methyl-N-nitrosourea, 1,2-dimethylhydrazine, or benzo(a)pyrene following partial hepatectomy or sham hepatectomy. This treatment by itself led to no hepatocellular carcinomas by 8 to 18 months, except in animals given N-methyl-N-nitrosourea, which showed a 30% incidence by 12 months. With each treatment regimen, exposure to dietary 2-acetylaminofluorene for 2 weeks coupled with partial hepatectomy or the administration of a necrogenic dose of CCl4, was associated with an incidence of 68 to 94% of cancer at 8, 12, or 18 months, depending upon the initiating carcinogen used. Appropriate controls showed either no hepatocellular carcinoma or a much lower incidence. It is concluded that the 2-week exposure to dietary 2-acetylaminofluorene plus partial hepatectomy or the administration of CCl4 has a strong promoting effect on liver carcinogenesis with four different chemical carcinogens.

1 This research was supported by grants from the National Cancer Institute of Canada; the National Cancer Institute, NIH (CA-21157); and the Medical Research Council of Canada (MT-5594). A preliminary report of some of this research was presented at the meeting of the American Association for Cancer Research in May 1980 (1).

2 Present address: Department of Pathology, Northwestern University School of Medicine, Chicago, Ill.

3 Present address: Centro de Investigationes Biomedicas, Universidad de Carabobo Maracay, Venezuela.

4 Present address: First Department of Pathology, Nagoya City University Medical School, 1 Kawasumi, Mizubo-cho, Mizuho-ku, Nagoya 467, Japan.

5 Present address: Department of Pathology, Sapporo Medical College, S. 1, W.7 Chuo-ku, Sapporo 060, Japan.

6 To whom requests for reprints should be addressed.

Received 3/ 8/82. Accepted 9/ 3/82.




This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
X. Jia, C. Han, and J. Chen
Effects of Tea on Preneoplastic Lesions and Cell Cycle Regulators in Rat Liver
Cancer Epidemiol. Biomarkers Prev., December 1, 2002; 11(12): 1663 - 1667.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Laconi, P. Pani, S. Pillai, D. Pasciu, D. S. R. Sarma, and E. Laconi
A growth-constrained environment drives tumor progression invivo
PNAS, June 20, 2001; (2001) 131210498.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
A. Yusuf, P. M. Rao, S. Rajalakshmi, and D. S.R. Sarma
Development of resistance during the early stages of experimental liver carcinogenesis
Carcinogenesis, August 1, 1999; 20(8): 1641 - 1644.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Laconi, P. Pani, S. Pillai, D. Pasciu, D. S. R. Sarma, and E. Laconi
A growth-constrained environment drives tumor progression invivo
PNAS, July 3, 2001; 98(14): 7806 - 7811.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1983 by the American Association for Cancer Research.